Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

The brokerage foresees strong performances from Lupin, Torrent, Ipca and Apollo Hospital, while Aurobindo and Max Healthcare may show more muted results.

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

But sector headwinds must also be considered to temper expectations from Pharma. Easing of US FDA plant inspection concerns contributed to the multiple expansion. Cipla, Aurobindo, Lupin ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape. - Issue Date: ...